Another study used 3D-CNN in 94 cases of IDH mutation to associate multiparametric imaging characteristics with glioma IDH mutations, and 120 wild-type gliomas exhibited a higher effectiveness, attaining 98% sensitivity, 97% specificity and an AUC of 99% (39). The gene discussed is IDH1; the disease is glioma.